an ageing society, adequate provision of appropriately trained human resources is essential. The nurse practitioner (NP) is an autonomous and independent, advanced practice nurse capable of providing treatment and care that can be substituted for some aspects of a medical doctor's (MD's) role, especially in a community setting. Previous systematic reviews found higher levels of patient satisfaction with services provided by NPs than those provided by MDs. As noncommunicable diseases become a major health burden requiring long-term healthcare in community settings, this systematic review aims to assess the equivalence of NP services to standard care provided by MDs, and to determine whether their practice is an effective alternative to that of MDs in community settings.
Methods and analysis: Relevant randomised controlled trials (RCTs) and cluster RCTs will be searched in the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL and the British Nursing Index. We will assess patient and health system utilisation outcomes of interventions comparing treatment and care provided by NPs in community settings with that provided by MDs. Two authors will independently screen studies for inclusion, consulting with a third author where necessary to resolve discrepancies. The risk of bias of included studies will be assessed using the Cochrane Collaboration risk of bias tool, and quality of evidence using the GRADE approach. Meta-analysis of included studies will be conducted using fixed-effect or random-effects models depending on the degree of between-study heterogeneity. Results will be presented using risk ratios with 95% CI for dichotomous outcomes and standardised mean differences with 95% CI for continuous outcomes.
Ethics and dissemination: This systematic review
and meta-analysis protocol does not require ethical approval. We will disseminate the findings of this systematic review and meta-analysis via publications in peer-reviewed journals.
INTRODUCTION
The percentage of the world's population aged 60 years and above is estimated to double from approximately 11% to 20% by 2050. 1 To realise and sustain universal health coverage (UHC) in an ageing society, adequate provision of well-prepared human resources for health (HRH) is essential. 2 Nurses constitute the largest profession in the world, 3 and are the frontline-often the only -healthcare personnel available to the population, especially in a community setting. It is therefore important to secure a practical environment that enables nurses to optimise their expertise to provide a high quality of services.
A nurse practitioner (NP) is a type of advanced practice nurse (APN) defined by the International Council of Nurses as "a registered nurse who has acquired an expert knowledge base, complex decisionmaking skills and clinical competencies. A master's degree is recommended for entrylevel positions". 4 Although many countries have introduced a NP system, the status of education, regulations, code of practice and competencies, vary substantially across countries and regions. 5 Many countries with limited HRH are seeking ways to improve the efficiency of healthcare delivery, and utilising NPs is one solution that may enable the provision of primary healthcare with advanced scope of practice. For instance, in a community setting where NPs are the first point of contact, such as at a nursing home, geriatric healthcare facility, home-visit nursing agency, in the home or at the clinic, the NP performs assessments and diagnoses, orders diagnostic and laboratory tests, prescribes medication and offers treatments with a high level of autonomy and independence. Also taking responsibility for case management, the NP monitors patient health and medical plan adherence, offers counselling and education for non-communicable disease (NCD) prevention, ensures continuity of care and manages hospital readmission. The NP is also responsible for disease symptom management and is expected to show advanced consultation, collaboration, education, research and leadership skills. 4 6 With NCDs becoming a major burden on population health globally, 7 the credentials and competencies of NPs may be beneficial in the management of NCDs, which requires long-term care in primary-care settings, especially in countries with an increasing ageing population. Moreover, NPs are in charge of managing individual health in communities with few medical doctors (MD). 8 It is essential to assure that NP practice is sufficiently effective to make up for the shortage of MDs, and/or can be equivalent to care provided by MDs in a community setting.
Two comprehensive systematic reviews have previously assessed NP practice. 9 10 One review, conducted in 2002, examined the equivalence of services provided by NPs and by MDs in primary care. 9 This systematic review and meta-analysis of 11 trials and 23 observational studies identified higher levels of patient satisfaction with services provided by NPs than those provided by MDs, and no significant difference in patient health status, prescriptions and return consultations. The other review quantified APN outcomes, including NPs, from articles published in the USA between 1990 and 2008. 10 This study identified 14 trials including 12 high quality scaled studies and 23 observational studies. From these trials, NP practice outcomes were summarised in dimensions of patient satisfaction, self-rated health, physical function and biological data such as blood sugar control, lipid control and blood pressure. These outcomes were compared with the same outcomes in patients whose care was managed exclusively by MDs. However, no systematic review or meta-analysis has focused on NP practice specifically in a community setting. As services provided by NPs vary depending on the setting, we will conduct a systematic review and meta-analysis focusing on NP practice in the community settings.
Objectives
The main objective of this study is to investigate whether services delivered through substitution of NPs for MDs result in statistically equivalent patient and health system utilisation outcomes compared to standard care provided by MDs in a community setting.
METHODS

Type of studies
Randomised controlled trials (RCTs) and cluster RCTs of interventions comparing NPs and MDs will be included. We will not include quasi-RCTs and cross-over trials.
This review protocol has been registered with the International Prospective Register of Systematic Reviews (PROSPERO) at the National Institute for Health Research and Center for Reviews and Dissemination (CRD) at the University of York (registration number: CRD42014009627).
Type of participants
The participants will be adults receiving treatment and care from NPs in a community setting. Community settings include nursing homes, geriatric healthcare facilities, home-visit nursing agencies, patient homes and clinics that cover all areas except hospital inpatients.
Type of intervention
The types of interventions by NPs will be as follows: ▸ As a first point of contact for patients or clients, performing assessments, and ordering diagnostic and laboratory tests; ▸ Offering diagnoses, and prescribing medications and treatments; ▸ Implementing procedures; ▸ Taking responsibility for case management; ▸ Following up and monitoring patient health and medical plan adherence; ▸ Counselling and providing education for preventing NCDs; ▸ Ensuring continuity of care and hospital re-admission; ▸ Disease symptom management.
All interventions are provided by NPs in a community setting. Search strategy and sources We will report data following the preferred reporting items for systematic review and meta-analysis (PRISMA) statement. 11 A comprehensive literature review using the databases MEDLINE, EMBASE, CINAHL, British Nursing Index and Cochrane Central Register of Controlled Trials (CENTRAL) will be performed; an example of search strategy in MEDLINE is shown in online supplementary file 1. Search strategies will be tailored to each database so as to employ the correct Medical Subject Headings (MeSH) terms. Where possible, MeSH and free text terms with synonyms will both be used so as to increase identification of potentially relevant studies. Where MeSH terms are not used, free text only will be used. A separate search of Web of Science will be undertaken in order to capture any grey literature. Reference list reviews of included papers will be carried out. No language restrictions will be applied to the searches. 
TYPE OF OUTCOME MEASURES
DATA COLLECTION AND ANALYSIS
Data extraction and management
The study title and abstract will be screened by two authors in the review group independently to identify eligible studies. Two authors in the study group will manually enter data into a standard data extraction form based on the Cochrane Handbook for Systematic Reviews of Interventions, 12 to determine the eligibility of each study. Any disagreement will be resolved by discussion. If there is any discrepancy between the two authors, we will consult with other authors (EO, SaM and KS) for expert opinion. When there is unclear information in the process of data extraction, we will contact the authors of the original studies to provide further information.
Assessment of risk of bias in included studies
The risk of bias in included studies will be assessed using the Risk of Bias tool according to the Handbook. 12 We will use the following criteria to assess the risk of bias: random sequence generation, allocation sequence concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and other bias. 12 Studies will be included in meta-analysis if they are of the same type, such as RCTs or cluster RCTs, and have the same population, intervention, comparison and outcomes. Evaluation of whether or not included studies are eligible for meta-analysis will be conducted by four authors (MK, EO, HF and SG), and in the event of disagreement, we will consult with other authors (EO, SaM and KS) for expert opinion.
Measurement of treatment effect
Statistical analysis will be carried out using RevMan 2014. 13 For dichotomous outcomes including hospitalisation, patient mortality and emergency department use, risk ratios with 95% CIs will be used to assess differences in the outcomes of treatment and care provided by NPs compared to MDs. For continuous outcomes including biological data, cost, patient satisfaction, self-reported perceived health and functional status (ADL/IADL), standardised mean differences with 95% CI will be calculated.
Missing data
We will assess levels of attrition for included studies, and conduct sensitivity analysis of the impact of including studies with 20% or more of missing data. For all outcomes, we will conduct intention-to-treat analysis wherever possible.
Assessment of publication bias
If a sufficient number (10 or more) of studies are eligible for meta-analysis, funnel plots will be used in order to assess reporting bias by checking funnel plot asymmetry.
Strategy for data synthesis, assessment/investigation of heterogeneity We will use a fixed-effect model for combining data if the interventions examined in the studies are judged to be the same based on the heterogeneity between studies, and if the methods are fairly similar. We will use a random-effects model when the interventions in the studies are considered to have clinical heterogeneity or there is substantial heterogeneity between studies. The results of the random-effects model will be used as the average range of possible intervention effects with 95% CIs, and the estimates of τ 2 and I 2 and difference of
